HomeHealthFortis Bannerghatta Road Makes History by Successfully Performing Karnataka's First Edwards Sapien...

Fortis Bannerghatta Road Makes History by Successfully Performing Karnataka’s First Edwards Sapien 3 Ultra Valve Replacement Surgery, Restoring Mobility for 75-Year-Old Patient from Mizoram

– The patient was wheelchair-bound for 04 Months, – was able to walk unassisted post 4 hours of the procedure –

Bengaluru, 30 May 2024: In a First in Karnataka, Fortis Hospital Bannerghatta Road successfully treated a 75-year-old patient from Mizoram, with TAVR (Transcatheter Aortic Valve Replacement) using the latest and most advanced Edwards Sapien 3 Ultra Valve. Under the care and supervision of Dr. Srinivas Prasad BV, Senior Consultant – Interventional Cardiology at Fortis Hospital, Bannerghatta Road, the procedure was completed in mere 45 minutes.

Mr. Vanlalzaunga, who has a history of spinal surgery, was diagnosed with Aortic Valve Stenosis (occurs when the aortic valve narrows and blood cannot flow normally) in 2011. Battling with the heart condition, he visited numerous hospitals and received medical management, however, could not find a permanent solution. His condition worsened, leaving him wheelchair-bound. Seeking a lasting remedy, his family turned to Fortis Hospital, Bannerghatta Road, where he was advised to undergo TAVR—a minimally invasive procedure used to replace a narrowed aortic valve that fails to open properly.

Speaking about the advancements in heart valve replacement procedures, Dr. Srinivas Prasad BV, Senior Consultant – Interventional Cardiology, Fortis Hospital, Bannerghatta Road, said, “In traditional heart valve replacement surgeries, the recovery duration is longer with increased risks of complications. Transcatheter Aortic Valve Replacement (TAVR) has emerged as a less invasive alternative, offering quicker recovery times and reduced risks. However, in case of Mr. Vanlalzaunga, we performed TAVR utilising the latest and most advanced Edwards Sapien 3 Ultra valve, which is a first in Karnataka. This advanced technology in TAVR procedure provides improved valve sealing and minimizes the risk of complications during the procedure, thereby allowing the patient to return to his normal live sooner. This procedure which took just 45 minutes enabled the patient to walk independently mere hours after the surgery”

Patient, Mr. Vanlalzaunga said, “I am immensely grateful to Dr. Srinivas Prasad and the entire team at Fortis Hospital Bannerghatta Road for their exceptional care and expertise. We are glad to have come to Fortis for treatment where we learned about the advanced treatment procedure like TAVR with the Edwards Sapien 3 Ultra valve. We had been to many hospitals, but none informed us about such a treatment. Fortis has truly transformed my life with its exceptional care and expertise. Being able to walk independently just hours after the procedure was beyond my expectations. I am now looking forward to enjoying an improved quality of life, thanks to Fortis Hospital’s cutting-edge technology and compassionate care.”

Mr. Akshay Oleti, Business Head, Fortis Hospitals, Bengaluru, added, “This successful utilisation of the latest and most advanced Edwards Sapien 3 Ultra valve in TAVR is a testament to our dedication to offering patients the most cutting-edge solutions for their heart health. We’re proud to be the first in Karnataka to bring this life-changing technology to our patients. This case underscores Fortis Healthcare’s dedication to patient care and cutting-edge technology.”

About Fortis Healthcare Limited

Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 28 healthcare facilities, 4,500+ operational beds (including O&M facilities) and over 400 diagnostics centers (including JVs). Fortis is present in India, United Arab Emirates (UAE), Nepal & Sri Lanka. The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs ~23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular